https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

Research News – Monday, June 17, 2024


Published: Monday, June 17, 2024

WORKSHOPS AND SEMINARS

 
OCAST Training – Intellectual Property (IP) Basics Training and Networking Session
Wednesday, June 26, 2024 from 110:00AM to 1:00PM
For additional information see attached document.
 
Register Now for Effective Publication Strategies: 12 Tips for Selecting the Right Journal for Your Research and Scholarship
In this free webinar, learn key strategies for finding the right home for your scholarship and maximizing your publication success. Explore how the recently updated AAMC Group on Educational Affairs (GEA) Medical Education Scholarship Research and Evaluation (MESRE) Annotated Bibliography can serve as an essential, trusted resource in your academic medicine journey. This session is part of a series, co-sponsored by Academic Medicine and MedEdPORTAL, that covers the importance of publishing your education scholarship and practical suggestions for how to do so successfully. All are invited to attend on Monday, June 24 at 12:00 p.m. ET.
 

FUNDING OPPORTUNITIES

 
The Searle Scholars Program makes grants to selected universities and research institutes to support the independent research of exceptional young faculty in the biomedical sciences and chemistry. Applicants for the 2025 competition are expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences. The 2025 award will be in the amount of $300,000 ($100,000 per year for three years).  Details can be found at https://searlescholars.org/ and in the attached announcement. 
 
Cycles I-III PHF TAG Grant Program Deadline: ROLLING APPLICATIONS
The TAG program replaces the Equipment grant program. The primary objective of the PHF TAG program is to provide partial funding for critically needed research equipment that could be transformative for the research mission at OUHSC. This program is fully aligned with Pillar 1 of the Strategic Plan. The TAG program will proactively and with the help of a committee address campus-wide needs and fill critical gaps, with the goals to grow the research enterprise, expand innovative technology and research infrastructure, and promote addition of new cutting-edge technology on campus. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. Funds may be used for equipment to be purchased as part of a recruitment package for new faculty or for equipment to support the research of current faculty. If the funds will be used for a new recruit, the recruit must have signed the offer letter with a specific start date or specific start date time frame. Equipment and/or technology funded by PHF is expected to be made available to all researchers at OUHSC, whenever possible. All OUHSC Assistant, Associate, or Full Professors are eligible to apply. Applicants are required to match requested funds. The maximum allowable budget for this program is $500,000 (PHF funding: $250,000; Applicant funding: $250,000). The minimum allowable budget for this program is $60,000 (PHF funding: $30,000; Applicant funding:  $30,000). Only one application will be accepted per investigator per year.  Refer to Attachment.
 

CLINCIAL STUDY ANNOUNCEMENTS

***************************************************
Please note this is NOT a solicitation for study subjects
***************************************************
Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:
  • A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years of Age
  • Potential hereditary haemochromatosis trial researching ferroportin inhibitor in patients unable to tolerate phlebotomy treatments
  • Pfizer Announces a New Research Grants RFP in Multiple Myeloma
    • Projects that will be considered for Pfizer support will focus on generating evidence on priority gaps in the use of elranatamab in multiple myeloma across lines of treatment.
  • Pfizer Global Medical Grants Announces a New Education RFP in Cervical Cancer
    • The goal of this RFP is to support education for medical oncologists, gynecologic oncologists, pharmacists, eye care providers, nurse practitioners and physician assistants working in the oncology setting caring for patients with r/m cervical cancer relating to treatments, management of adverse events, and long-term outcomes.
  • Pfizer and Astellas request for Proposals (RFP) Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
  • Pfizer Global Medical Grants Announces a New Education RFP in Gene TherapyGene and Gene-modified Cell Therapies Medical Education
  • Arvinas and Pfizer Request for Proposals (RFP) for New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
    • Increasing understanding of emerging and novel therapeutic agents in the evolving treatment landscape of ER+/HER2- mBC
    • Exploring the current unmet needs in ER+/HER2- mBC, including the relevance and applicability of biomarker testing
Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research Administration.
 

NIH NOTICES

 
(NOT-OD-24-133)
(NOT-AT-24-043)
 
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.
 

NIH FUNDING OPPORTUNITIES

 
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (PAR-24-204)
Application Deadlines:  March 18, 2025
 
 
 
 
 
 
 
 
 
 
 
Other Funding Opportunities
 
BrightFocus’ Alzheimer’s Disease Research program is requesting proposals for FY25 (award start date July 01, 2025).
Letters of Intent are now being accepted with a deadline of August 02, 2024.
 
OCASCR Grant Deadline: September 27,2024
Proposals will be accepted for large and small equipment, research, and education/travel grants. For additional information go to:
 
Susan G. Komen is excited to announce two Komen Funding Opportunities: Career Transition Awards (CTA) and Career Catalyst Research (CCR) grants. 
Both grant mechanisms are limited submission opportunities: each institution may submit up to two nominees to apply for each funding opportunity, if at least one of the two nominees identifies as someone from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data, including Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders, and individuals with disabilities, as well as individuals from disadvantaged backgrounds. Research projects must be hypothesis-driven, breast cancer-focused studies. 
Institutions must respond to missiongrantsadmin@komen.org by June 26, 2024, to indicate that they are opting-in to the institutional nomination process.  

Documents to download